Your Shopping Cart
No Items
Written by GHS team member Garth Hogan
The Newmark Global Healthcare services national team, had its biggest year of volume since the formation of the group nearly 4 years ago and project a significant increase in 2016. The demand for new and more efficient clinical space as well as the reallocation of capital on both the provider and investor side has stimulated most of this activity. The healthcare capital markets continue to show signs of strength ahead of an expected interest rate hike by the Fed and headwinds from the selloff in healthcare REIT stocks. MOB sale transactions for 2015 are on track to outpace 2014’s record-setting volume of $9.879 billion (RCA). Q3 ’15 closed with over $2.535 billion (RCA) in MOB transactions totaling $8.727 billion YTD. While transaction volume remains high, cap rates appear to have plateaued. The average MOB cap rate for Q3 ’15 was 7.18%, a 4 basis point increase from Q2 ’15 and a 9 basis point increase from Q1 ’15. The below graph compares MOB historical sales volume and cap rate trends (RCA).
Posted on 04/23/2016 at 11:00 PM
All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.
